by Texas Tech University Nadia German, Ph.D., (right) and collaborator Constantinos Mikelis, Ph.D., have received a U.S. patent for a chemical that targets the brain’s dopamine transporter. Credit: TTUHSC Many brain diseases and disorders lead to neuroinflammation, a swelling of brain tissue that is increasingly recognized as one ofthe telltale signs and disease progression factors...
